ReviewDiagnostics (Basel, Switzerland)2024
Wolf-Parkinson-White Syndrome: Diagnosis, Risk Assessment, and Therapy-An Update.
Review in Diagnostics (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 19 citations in OpenAlex.
- Do Stimulants Promote Arrhythmic Risk: Insights From a Human-Induced Pluripotent Stem Cell-Derived Cardiomyocyte Model.Journal of arrhythmia · 2026Article
- Wolff-Parkinson-White syndrome in a patient with type I Chiari malformation: management of an unusual association.Annals of medicine and surgery (2012) · 2026Article
- Cardiac screening in adolescents: Insights from a 15-year Student Heart Check program.Heart rhythm O2 · 2026Article
- Explainable deep learning-based classification of Wolff-Parkinson-White electrocardiographic signals.Frontiers in physiology · 2026Article
- Arrhythmias in Pediatric Age: A Narrative Review.Children (Basel, Switzerland) · 2025Review
- Intermittent Ventricular Pre-Excitation: Clinical Features and Electrophysiological Properties.Journal of cardiovascular electrophysiology · 2025Article
- Article
- [Wolff-Parkinson-White syndrome due to cocaine use: a case report].Revista medica del Instituto Mexicano del Seguro Social · 2025Article
- Unmasking of Wolff-Parkinson-White syndrome following cardioversion of ventricular tachycardia in pregnancy: a case report.Journal of medical case reports · 2025Article
- A Comprehensive Review of a Mechanism-Based Ventricular Electrical Storm Management.Journal of clinical medicine · 2025Review
- Risk stratification and management of arrhythmias in patients with Wolff-Parkinson-White syndrome.Annals of medicine and surgery (2012) · 2025Review
- Wolff-Parkinson-White Mimicking Posterior STEMI: When Even AI Gets It Wrong.Clinical case reports · 2025Article
- A 29-Year-Old Man With Type 2 Hermansky-Pudlak Syndrome and Wolff-Parkinson-White Syndrome: The Hypothesis of a Potential Link Between These Two Conditions.Case reports in medicine · 2025Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 4 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Wolf-Parkinson-White (WPW) syndrome is a disorder characterized by the presence of at least one accessory pathway (AP) that can predispose people to atrial/ventricular tachyarrhythmias and even sudden cardiac death. It is the second most common cause of paroxysmal supraventricular tachycardia in most parts of the world, affecting about 0.1-0.3% of the general population. Most patients with WPW syndrome have normal anatomy, but it may be associated with concomitant congenital heart disease or systemic diseases. Although many individuals are asymptomatic, during supraventricular arrhythmia episodes, they may experience severe symptoms, including syncope or even sudden cardiac death (mainly due to pre-excited atrial fibrillation over rapidly conducting AP). In addition to arrhythmia-related symptoms, for some specific locations of the APs with overt anterograde conduction, there might be a reduction in exercise capacity mediated by a reduction in LV systolic performance due to anomalous LV depolarization. Although it is typically diagnosed through electrocardiography (ECG), additional tests are necessary for risk assessment. Management of WPW syndrome may be quite challenging and can vary from only acknowledging the presence of the accessory pathway to pharmacological treatment or radiofrequency ablation. Early diagnosis, risk assessment, and appropriate treatment are critical steps in the management of WPW syndrome, aiming to improve the quality of life and reduce the risk of life-threatening arrhythmias.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.